Jupiter Life Line Hospitals Reports 20.5% Revenue Growth in Q1, PAT Declines 1.6%
Jupiter Life Line Hospitals Limited reported a 20.5% year-on-year revenue growth for Q1, with total income reaching INR 347.60 crores. EBITDA increased by 19.6% to INR 78.10 crores. However, PAT decreased by 1.6% to INR 43.90 crores due to higher depreciation and finance costs from recent investments. The company added 100 new census beds, commissioned a 1.2 megawatt solar plant, and is progressing with three greenfield hospital projects. Despite lower occupancy rates, patient volumes increased by 11.7%. The company expects EBITDA margins to be preserved for the financial year but anticipates lower PAT margins.
01Aug 25
Jupiter Life Line Hospitals Reports Q1 Results: Revenue Up 20.5%, Profit Dips Slightly
Jupiter Life Line Hospitals Limited announced Q1 financial results with total income up 20.5% to ₹347.60 crore. Revenue growth driven by 19.6% increase in IPD and 15.5% in OPD. Net profit slightly down 1.6% to ₹43.90 crore. EBITDA up 19.6% to ₹78.10 crore. Operational improvements include 11.7% increase in patient volumes and 12.7% rise in ARPOB to ₹67,300. Expansion plans on track with Dombivli project and second Pune hospital. Company took on additional debt for expansion, leading to increased finance costs.
12May 25
Jupiter Life Line Hospitals Unveils Ambitious Expansion Plans Amid Improved Performance
Jupiter Life Line Hospitals has revealed plans to open three new hospitals in Dombivli, Pune, and Mira Road. The company reported a 10% increase in ARPOB and improved profit margins of 24%. With ₹600 crore in cash reserves, the hospital chain is exploring M&A opportunities in western India. While occupancy rates vary across units, the company's expansion strategy and financial performance indicate a robust growth trajectory.
09May 25
Jupiter Life Line Hospitals Reports Q4 Growth, Recommends Dividend
Jupiter Life Line Hospitals Ltd. released its Q4 FY2023 results, showing revenue growth of 12.76% to ₹3.27 billion and EBITDA increase of 25.56% to ₹782.00 million. The EBITDA margin improved to 23.94%. Despite these gains, net profit slightly decreased by 0.82% to ₹449.00 million. The company's board recommended a dividend of ₹1.00 per equity share for the financial year.
25Mar 25
Jupiter Life Line Hospitals Secures ₹610 Crore in Financial Assistance from HDFC Bank
Jupiter Life Line Hospitals Limited (JLHL) has secured a ₹610 crore loan agreement with HDFC Bank. The package includes a ₹350 crore term loan for capital expenditure, a ₹10 crore overdraft facility for working capital, and a ₹250 crore term loan for its subsidiary Jupiter Hospital Projects Private Limited (JHPPL) to repay an intercorporate loan. The loans are secured against hospital properties and assets in Dombivli and Indore. This financial move indicates JLHL's plans for significant growth and operational improvements.
24Mar 25
Jupiter Life Line Hospitals Secures 6.15 Billion Rupees in Loan Agreements with HDFC Bank
Jupiter Life Line Hospitals Limited (JLHL) and its subsidiary Jupiter Hospital Projects Private Limited (JHPPL) have entered into significant loan agreements with HDFC Bank. JLHL secured a 3.60 billion rupee package, including a 3.50 billion rupee term loan and a 100 million rupee overdraft facility, for capital expenditure. JHPPL obtained a 2.50 billion rupee term loan and a 50 million rupee overdraft facility to repay an intercorporate loan. Both entities provided substantial security for these loans. The company has closed its trading window for designated persons from April 1, 2025, until 48 hours after the declaration of FY2025 results.